📣 VC round data is live. Check it out!

Dr. Martens Valuation Multiples

Discover Dr. Martens' revenue and EBITDA valuation multiples and investment history, alongside public comparables like Vulcabras, Canada Goose, Bata India, Guess and more.

Dr. Martens Overview

About Dr. Martens

Dr. Martens PLC is engaged in the business of footwear. Its product segments include Originals, Fusion, Kids and Casual, and a complementary range of Accessories. The company has sales through E-commerce, Retail, and Wholesale of Products. Geographically, it derives a majority of revenue from EMEA and also has a presence in the Americas and APAC.


Founded

2021

HQ

United Kingdom

Employees

2.3K

Financials (LTM)

Revenue: $1B
EBITDA: $180M

EV

$1B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Dr. Martens Financials

Dr. Martens reported last 12-month revenue of $1B and EBITDA of $180M.

In the same LTM period, Dr. Martens generated $684M in gross profit, $180M in EBITDA, and $38M in net income.

Revenue (LTM)


Dr. Martens P&L

In the most recent fiscal year, Dr. Martens reported revenue of $1B and EBITDA of $172M.

Dr. Martens is profitable as of last fiscal year, with gross margin of 66%, EBITDA margin of 17%, and net margin of 3%.

See analyst estimates for Dr. Martens
LTMLast FY202320242025202620272028
Revenue$1B$1B$1B$1B$1B
Gross Profit$684M$681M$789M$710M$683M
Gross Margin66%66%65%65%66%
EBITDA$180M$172M$277M$178M$166M
EBITDA Margin17%17%23%16%16%
EBIT Margin11%10%16%9%8%
Net Profit$38M$32M$113M$28M$26M
Net Margin4%3%9%3%2%
Net Debt-$93M---

Financial data powered by Morningstar, Inc.

Dr. Martens Stock Performance

Dr. Martens has current market cap of $931M, and enterprise value of $1B.

Market Cap Evolution


Dr. Martens' stock price is $0.97.

Dr. Martens share price decreased by 2.3% in the last 30 days, and by 2.9% in the last year.

Dr. Martens has an EPS (earnings per share) of $0.03.

See more trading valuation data for Dr. Martens
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$1B$931M-2.2%-2.3%13.9%-2.9%$0.03

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Dr. Martens Valuation Multiples

Dr. Martens trades at 1.2x EV/Revenue multiple, and 6.8x EV/EBITDA.

See NTM and 2027E valuation multiples for Dr. Martens

EV / Revenue (LTM)


Dr. Martens Financial Valuation Multiples

As of June 3, 2026, Dr. Martens has market cap of $931M and EV of $1B.

Dr. Martens has a P/E ratio of 24.6x.

LTMLast FY202320242025202620272028
EV/Revenue1.2x1.2x1.0x1.1x1.2x
EV/EBITDA6.8x7.1x4.4x6.9x7.3x
EV/EBIT11.2x11.5x6.4x12.3x15.3x
EV/Gross Profit1.8x1.8x1.5x1.7x1.8x
P/E24.6x29.1x8.2x33.5x36.5x
EV/FCF15.8x6.9x8.1x5.4x6.4x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Dr. Martens Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Dr. Martens Margins & Growth Rates

Dr. Martens grew revenue by 3% and EBITDA by 27% in the last fiscal year.

In the most recent fiscal year, Dr. Martens reported gross margin of 66%, EBITDA margin of 17%, and net margin of 3%.

See estimated margins and future growth rates for Dr. Martens

Dr. Martens Margins

Last FY202420252026202720282029
Gross Margin66%65%66%67%
EBITDA Margin17%16%16%20%
EBIT Margin10%9%8%11%
Net Margin3%3%2%5%
FCF Margin17%21%18%9%

Dr. Martens Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth3%(11%)(5%)1%
Gross Profit Growth4%(10%)(4%)3%
EBITDA Growth27%(36%)(6%)24%
EBIT Growth16%(48%)(20%)41%
Net Profit Growth106%(75%)(8%)125%
FCF Growth(62%)51%(15%)(51%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Dr. Martens Operational KPIs

Dr. Martens' revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.3M for the same period.

Dr. Martens' Rule of 40 is 21% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Dr. Martens' Rule of X is 23% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Dr. Martens
LTMLast FY202320242025202620272028
Rule of 4021%21%---
Bessemer Rule of X26%23%---
Revenue per Employee-$0.4M---
Opex per Employee-$0.3M---
S&M Expenses to Revenue7%7%--7%
G&A Expenses to Revenue-(0%)(0%)(0%)(0%)
Opex to Revenue-58%49%56%58%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Dr. Martens Competitors

Dr. Martens competitors include Vulcabras, Canada Goose, Bata India, Guess, Guararapes, Vivara, Relaxo Footwears, Vedant Fashions, Synsam and Safari Indus (India).

Most Dr. Martens public comparables operate across Clothing & Accessories.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Vulcabras1.5x1.5x5.0x6.5x
Canada Goose1.1x1.1x6.1x6.0x
Bata India2.7x2.6x12.7x12.7x
Guess----
Guararapes0.6x-2.2x-
Vivara2.1x1.9x6.6x7.0x
Relaxo Footwears3.0x3.0x19.5x21.7x
Vedant Fashions6.7x6.6x13.4x15.1x

This data is available for Pro users. Sign up to see all Dr. Martens competitors and their valuation data.

Start Free Trial

Investments by Dr. Martens

Dr. Martens has invested in 1 company to date.

Latest investment by Dr. Martens was on March 29th 2023. Dr. Martens invested in Gen Phoenix in their $18M Series B round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Dr. Martens

Gen Phoenix
Description
Gen Phoenix is a Seoul-based manufacturer that produces regenerated leather sheets from post-consumer and production leather waste through a proprietary fiber recovery process. The company blends recovered leather fibers with bio-based binders to form materials matching virgin leather's strength and aesthetics for applications in automotive interiors, fashion accessories, and electronics cases. Gen Phoenix supplies brands including Hyundai Mobis and Samsung Electronics with traceable, circular materials verified via blockchain-enabled digital passports. Headquartered in South Korea since its 2021 launch, the firm operates a production facility in Pyeongtaek capable of processing thousands of tons of waste annually into customizable sheets.
HQ CountryUnited Kingdom
HQ City
Peterborough
Deal Date29 Mar 2023
RoundSeries B
Raised$18M
InvestorsDr. Martens; ETF Partners; Hermes GPE; InMotion Ventures; Material Impact; Tapestry
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Dr. Martens investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Dr. Martens

When was Dr. Martens founded?Dr. Martens was founded in 2021.
Where is Dr. Martens headquartered?Dr. Martens is headquartered in United Kingdom.
How many employees does Dr. Martens have?As of today, Dr. Martens has over 2K employees.
Who is the CEO of Dr. Martens?Dr. Martens' CEO is Ije Nwokorie.
Is Dr. Martens publicly listed?Yes, Dr. Martens is a public company listed on London Stock Exchange.
What is the stock symbol of Dr. Martens?Dr. Martens trades under DOCS ticker.
When did Dr. Martens go public?Dr. Martens went public in 2021.
Who are competitors of Dr. Martens?Dr. Martens main competitors include Vulcabras, Canada Goose, Bata India, Guess, Guararapes, Vivara, Relaxo Footwears, Vedant Fashions, Synsam, Safari Indus (India).
What is the current market cap of Dr. Martens?Dr. Martens' current market cap is $931M.
What is the current revenue of Dr. Martens?Dr. Martens' last 12 months revenue is $1B.
What is the current revenue growth of Dr. Martens?Dr. Martens revenue growth (NTM/LTM) is 3%.
What is the current EV/Revenue multiple of Dr. Martens?Current revenue multiple of Dr. Martens is 1.2x.
What is the current EBITDA of Dr. Martens?Dr. Martens' last 12 months EBITDA is $180M.
What is Dr. Martens' EBITDA margin?Dr. Martens' last 12 months EBITDA margin is 17%.
What is the current EV/EBITDA multiple of Dr. Martens?Current EBITDA multiple of Dr. Martens is 6.8x.
What is the current FCF of Dr. Martens?Dr. Martens' last 12 months FCF is $77M.
What is Dr. Martens' FCF margin?Dr. Martens' last 12 months FCF margin is 7%.
What is the current EV/FCF multiple of Dr. Martens?Current FCF multiple of Dr. Martens is 15.8x.
How many companies Dr. Martens has acquired to date?Dr. Martens hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Dr. Martens has invested to date?As of June 2026, Dr. Martens has invested in 1 company.
What was the last Dr. Martens investment?On 29th March 2023 Dr. Martens invested in Gen Phoenix, participating in a $18M Series B round, alongside ETF Partners, Hermes GPE, InMotion Ventures, Material Impact, and Tapestry.
In what companies Dr. Martens invested in?Dr. Martens invested in Gen Phoenix.

See public comps similar to Dr. Martens

Lists including Dr. Martens

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial